GSK PLC Stock Price, News & Analysis

GSK and IQVIA have launched Vaccine Track, a new platform to enhance data transparency regarding adult vaccinations in the US. This resource aims to address the decline in adult immunization rates, particularly among minority populations, which saw an 18% drop in overall claims for recommended vaccinations from 2019 to 2021. The platform provides quarterly updates and diverse trend analyses, supporting public health efforts to improve vaccination rates post-pandemic. The initiative emphasizes the importance of vaccination data and could significantly impact public health policy.

GSK has received FDA approval for Benlysta (belimumab), making it the first biologic treatment for children aged 5 to 17 with active lupus nephritis (LN). This approval expands Benlysta's indications in the U.S. to include both lupus and active LN in pediatric patients. Lupus nephritis can lead to severe kidney complications. The treatment focuses on preserving renal function while reducing toxicities associated with traditional therapies. GSK aims to enhance treatment options and outcomes for children facing this serious condition.

GSK has initiated shipping of its FLULAVAL QUADRIVALENT and FLUARIX QUADRIVALENT influenza vaccines to US healthcare providers for the 2022-23 season, following FDA approval. The company aims to distribute over 50 million doses to support annual immunization efforts. Despite extensive public health campaigns, vaccination rates in the US remain consistent with previous seasons. GSK emphasizes the need for increased awareness, particularly in underserved communities. Both vaccines are approved for patients aged six months and older, aligning with CDC recommendations.

GSK has awarded the inaugural £70,000 grant (about $100,000) to the HealthTree Foundation for its "HealthTree Equity and Diversity for Multiple Myeloma Program." This initiative aims to address disparities in care for underserved communities and minority patients. The funding will support digital tools for education and outreach, including programs like "Black Myeloma Health" and "HealthTree for Mieloma Multiple" to enhance information access and community engagement. GSK emphasizes its commitment to innovation in the multiple myeloma community through this initiative.

GSK has received FDA approval for PRIORIX, a measles, mumps, and rubella (MMR) vaccine, aimed at individuals aged 12 months and older. This marks the vaccine's debut in the US market, where it adds to GSK's pediatric vaccine offerings, currently distributed in over 100 countries with more than 800 million doses. The FDA's approval comes in response to recent measles outbreaks and declining vaccination rates in children, emphasizing the need for additional vaccine options to protect against these highly-contagious diseases.

GlaxoSmithKline's TUMS®, America’s leading heartburn brand, has launched a new campaign titled 'Love Food Back', aimed at encouraging consumers to embrace their favorite foods without fear of heartburn. This campaign pivots from a decade-long focus on combating heartburn to celebrating food enjoyment. The strategy includes interactive elements, such as the TUMS® Cam Sweepstakes, and features engaging advertisements showcasing humorous relationships between consumers and food. The campaign aims to redefine the emotional association with food and heartburn relief.

Pfizer announced plans to exit its 32% ownership interest in Haleon, the new standalone company formed post-GSK demerger. This move aims to maximize shareholder value. The demerger, involving GSK transferring approximately 80% of its consumer healthcare business to GSK shareholders, will be completed by July 2022. Haleon will also pursue a listing on the New York Stock Exchange. Key legal and financial advisors, including Morgan Stanley and Guggenheim Securities, are engaged in the process. This strategic decision aligns with Pfizer's focus on innovative medicines and vaccines.

GSK Consumer Healthcare has launched CareWalks, an initiative to support caregivers, in partnership with actress Jennie Garth. This program provides resources and encourages movement to alleviate pain associated with caregiving duties. Data reveals that 94% of caregivers report musculoskeletal pain, with many struggling to provide care due to this discomfort. The initiative includes a video series featuring caregivers' stories, email resources, and a charitable donation to Volunteers of America. Voltaren Arthritis Pain Gel is highlighted as a key product for managing osteoarthritis pain.